Deborah L. French

7.4k total citations · 1 hit paper
134 papers, 5.3k citations indexed

About

Deborah L. French is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Deborah L. French has authored 134 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 56 papers in Hematology and 28 papers in Immunology. Recurrent topics in Deborah L. French's work include Platelet Disorders and Treatments (33 papers), CRISPR and Genetic Engineering (23 papers) and Pluripotent Stem Cells Research (22 papers). Deborah L. French is often cited by papers focused on Platelet Disorders and Treatments (33 papers), CRISPR and Genetic Engineering (23 papers) and Pluripotent Stem Cells Research (22 papers). Deborah L. French collaborates with scholars based in United States, Canada and United Kingdom. Deborah L. French's co-authors include Paul Gadue, James P. Quigley, Matthew D. Scharff, Hideaki Nagase, John Sipley, Elizabeth Hahn-Dantona, Jason A. Mills, Reuven Laskov, Barry S. Coller and Mortimer Poncz and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Deborah L. French

125 papers receiving 5.2k citations

Hit Papers

Activation of Matrix Metalloproteinase-9 (MMP-9) via a Co... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah L. French United States 38 2.4k 1.4k 1.0k 1.0k 741 134 5.3k
Feng‐Chun Yang United States 39 2.8k 1.1× 1.2k 0.8× 560 0.6× 1.1k 1.1× 686 0.9× 131 5.6k
E. Camilla Forsberg United States 29 2.8k 1.2× 1.2k 0.8× 540 0.5× 2.1k 2.1× 449 0.6× 74 5.8k
Cheryl D. Helgason Canada 38 3.1k 1.3× 836 0.6× 742 0.7× 1.8k 1.7× 882 1.2× 71 5.2k
Reuben Kapur United States 41 2.8k 1.1× 1.3k 0.9× 568 0.6× 2.4k 2.4× 932 1.3× 172 6.0k
Bi‐Sen Ding United States 37 2.9k 1.2× 701 0.5× 770 0.8× 896 0.9× 754 1.0× 74 6.4k
Andre C. Schuh Canada 35 4.9k 2.0× 2.5k 1.8× 1.0k 1.0× 868 0.9× 1.4k 1.8× 181 7.8k
Takuro Nakamura Japan 42 3.9k 1.6× 1.1k 0.8× 555 0.5× 1.3k 1.2× 1.9k 2.6× 214 7.1k
Roberta Mazzieri Australia 29 2.7k 1.1× 441 0.3× 1.3k 1.3× 1.3k 1.3× 1.3k 1.8× 60 5.2k
Linda J. Bendall Australia 31 1.6k 0.7× 1.7k 1.2× 537 0.5× 1.6k 1.6× 1.6k 2.1× 79 4.9k
Neil V. Morgan United Kingdom 42 3.0k 1.2× 807 0.6× 1.0k 1.0× 754 0.7× 505 0.7× 109 5.7k

Countries citing papers authored by Deborah L. French

Since Specialization
Citations

This map shows the geographic impact of Deborah L. French's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah L. French with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah L. French more than expected).

Fields of papers citing papers by Deborah L. French

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah L. French. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah L. French. The network helps show where Deborah L. French may publish in the future.

Co-authorship network of co-authors of Deborah L. French

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah L. French. A scholar is included among the top collaborators of Deborah L. French based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah L. French. Deborah L. French is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarkar, Amrita, Jeremy G. T. Wurtzel, Scott L. Diamond, et al.. (2026). Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic risk. Blood.
2.
Campbell, Clyde, Giulia Pavani, Radwa Barakat, et al.. (2024). p65 signaling dynamics drive the developmental progression of hematopoietic stem and progenitor cells through cell cycle regulation. Nature Communications. 15(1). 7787–7787.
3.
Leavens, Karla F., et al.. (2024). Generation of a fluorescent mNeonGreen insulin reporter line in the H1 (WA01) hESC background. Stem Cell Research. 81. 103559–103559.
4.
Pavani, Giulia, Jonathan Sussman, Kai Tan, et al.. (2024). Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells. Blood Advances. 8(6). 1449–1463. 7 indexed citations
5.
Barakat, Radwa, Giulia Pavani, Elizabeth Snella, et al.. (2023). Nod1-dependent NF-kB activation initiates hematopoietic stem cell specification in response to small Rho GTPases. Nature Communications. 14(1). 7668–7668. 7 indexed citations
6.
Kim, Oleg V., Rustem I. Litvinov, Alyssa Gagne, et al.. (2023). Megakaryocyte-induced contraction of plasma clots: cellular mechanisms and structural mechanobiology. Blood. 143(6). 548–560. 5 indexed citations
7.
Dawicki-McKenna, Jennine M., Elisa A. Waxman, Congsheng Cheng, et al.. (2023). Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching. Nature Communications. 14(1). 2628–2628. 17 indexed citations
8.
Campbell, Ian M., T. Blaine Crowley, Chintan Jobaliya, et al.. (2022). Platelet findings in 22q11.2 deletion syndrome correlate with disease manifestations but do not correlate with GPIb surface expression. Clinical Genetics. 103(1). 109–113. 4 indexed citations
9.
Hart, Matthew R., Donovan J. Anderson, Andriana G. Kotini, et al.. (2021). Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation. Blood Advances. 5(3). 687–699. 11 indexed citations
10.
Estevez, Brian, Danuta Jarocha, Michael V. Gonzalez, et al.. (2021). RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells. Blood. 137(19). 2662–2675. 21 indexed citations
11.
Cardenas‐Diaz, Fabian L., Karla F. Leavens, Siddharth Kishore, et al.. (2020). A Dual Reporter EndoC-βH1 Human β-Cell Line for Efficient Quantification of Calcium Flux and Insulin Secretion. Endocrinology. 161(2). 8 indexed citations
12.
Kishore, Siddharth, Elisa De Franco, Fabian L. Cardenas‐Diaz, et al.. (2020). A Non-Coding Disease Modifier of Pancreatic Agenesis Identified by Genetic Correction in a Patient-Derived iPSC Line. Cell stem cell. 27(1). 137–146.e6. 19 indexed citations
13.
Thorvaldsen, Joanne L., Deborah L. French, Alyssa Gagne, et al.. (2020). Derivation and investigation of the first human cell-based model of Beckwith-Wiedemann syndrome. Epigenetics. 16(12). 1295–1305. 5 indexed citations
14.
Posocco, David, Jean Ann Maguire, Deborah L. French, et al.. (2017). Customized Induced Pluripotent Stem Cell-Derived Red Cell Reagents. Blood. 130. 3–3. 2 indexed citations
15.
Beauvais, Geneviève, Noela Rodríguez-Losada, Ying Lei, et al.. (2017). Exploring the Interaction Between eIF2α Dysregulation, Acute Endoplasmic Reticulum Stress and DYT1 Dystonia in the Mammalian Brain. Neuroscience. 371. 455–468. 28 indexed citations
16.
Mills, Jason A., Kristin Hudock, Spencer K. Sullivan, et al.. (2015). Generation of poikiloderma with neutropenia (PN) induced pluripotent stem cells (iPSCs). Stem Cell Research. 15(3). 595–597. 1 indexed citations
17.
Antony‐Debré, Iléana, Nathalie Balayn, Dominique Bluteau, et al.. (2014). Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia. Blood. 125(6). 930–940. 71 indexed citations
18.
Garçon, Loïc, Jingping Ge, Jason A. Mills, et al.. (2013). Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood. 122(6). 912–921. 64 indexed citations
19.
Grimaldi, Christine & Deborah L. French. (1995). Monoclonal Antibodies by Somatic Cell Fusion. ILAR Journal. 37(3). 125–132. 3 indexed citations
20.
French, Deborah L., et al.. (1994). Monoclonal Antibodies to Human MMP‐9. Annals of the New York Academy of Sciences. 732(1). 469–471. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026